About Mahatma Gandhi Cancer Hospital & Research Institute (MGCH)
About Mahatma Gandhi Cancer Hospital & Research Institute (MGCH)
Mahatma Gandhi Cancer Hospital & Research Institute (MGCH) is one of India's premier comprehensive cancer care institutions, dedicated exclusively to the prevention, diagnosis, treatment, rehabilitation, and research of cancer. Established in 2005 by Dr. Murali Krishna Voonna in Visakhapatnam, Andhra Pradesh, the institute has grown into one of the largest and most trusted cancer centers in South India. Over nearly two decades, MGCH has earned a reputation for providing world-class oncology services through advanced medical technology, multidisciplinary expertise, cutting-edge treatment modalities, and compassionate patient-centered care. The hospital was founded with the vision of making high-quality cancer treatment accessible and affordable while advancing research and innovation in oncology.
Located in MVP Colony, Visakhapatnam, the hospital serves patients from Andhra Pradesh, Telangana, Odisha, Chhattisgarh, West Bengal, and other parts of India. The institution functions as a comprehensive cancer care center where patients can access every stage of oncology care under one roof, including cancer screening, diagnostics, surgery, chemotherapy, radiation therapy, bone marrow transplantation, rehabilitation, pain management, palliative care, and survivorship programs. This integrated approach ensures seamless coordination between specialists and improves treatment outcomes for patients facing complex cancer diagnoses.
Over the years, MGCH has achieved remarkable growth and clinical milestones. What began as a small cancer care initiative evolved into a dedicated oncology hospital equipped with advanced treatment technologies, specialized cancer departments, and a highly skilled team of oncologists. The institute has treated more than 150,000 cancer patients and has become a referral center for complex oncology cases across Eastern and Southern India. The hospital's commitment to clinical excellence, innovation, and ethical healthcare has earned it numerous national and regional recognitions.
One of the hospital's major strengths is its multidisciplinary cancer care model. Patients benefit from coordinated treatment planning through specialized tumor boards where surgical oncologists, medical oncologists, radiation oncologists, radiologists, pathologists, and supportive care specialists collaborate to design personalized treatment strategies. This evidence-based approach ensures that every patient receives comprehensive care tailored to their specific cancer type, stage, and overall health condition.
The Department of Surgical Oncology is among the most advanced units at MGCH. The department performs a wide range of cancer surgeries involving breast cancer, head and neck cancer, gastrointestinal cancers, thoracic cancers, gynecological cancers, urological cancers, and complex oncological procedures. The surgical team utilizes advanced techniques, including minimally invasive and robotic-assisted surgeries, to improve precision, reduce complications, and enhance recovery outcomes. The hospital's robotic surgery program has successfully completed hundreds of procedures, making it one of the pioneers of robotic oncology surgery in the region.
Radiation Oncology is another center of excellence at MGCH. The department offers advanced radiotherapy treatments using modern linear accelerators, stereotactic radiosurgery (SRS), stereotactic body radiotherapy (SBRT), image-guided radiation therapy (IGRT), intensity-modulated radiation therapy (IMRT), adaptive radiotherapy, and brachytherapy. These technologies allow oncologists to precisely target cancer cells while minimizing damage to surrounding healthy tissues, resulting in improved treatment outcomes and reduced side effects.
The Medical Oncology Department provides comprehensive chemotherapy, targeted therapy, immunotherapy, hormonal therapy, and systemic cancer treatments. Medical oncologists work closely with other specialists to develop individualized treatment plans that align with international oncology guidelines and emerging research. The department manages a broad spectrum of cancers while focusing on maximizing treatment effectiveness and preserving quality of life.
MGCH is particularly recognized for its expertise in Hemato-Oncology and Bone Marrow Transplantation (BMT). The institute operates a dedicated Bone Marrow Transplant Unit that provides both autologous and allogeneic stem cell transplantation services. Patients with leukemia, lymphoma, multiple myeloma, aplastic anemia, thalassemia, and other blood disorders receive specialized treatment through advanced transplant protocols and comprehensive supportive care. The hospital has successfully completed hundreds of bone marrow transplant procedures, making it one of the leading centers for hematological cancer treatment in the region.
The Pediatric Oncology Department provides specialized care for children diagnosed with cancer and blood disorders. Pediatric oncologists, hematologists, nurses, psychologists, and supportive care teams work together to provide age-appropriate treatment plans and family-centered care. The department treats childhood leukemia, lymphomas, brain tumors, sarcomas, and other pediatric malignancies while focusing on both clinical outcomes and emotional well-being.
Women's cancer care is delivered through the Gynaec Oncology Department, which specializes in the diagnosis and treatment of cervical cancer, ovarian cancer, uterine cancer, vulvar cancer, and other gynecological malignancies. The department combines surgical expertise, chemotherapy, radiation therapy, and supportive care to provide comprehensive treatment for women facing cancer-related health challenges. Breast oncology services also play a major role in the hospital's cancer care programs, offering advanced screening, diagnosis, surgery, and reconstruction services.
The hospital also houses specialized departments for Uro-Oncology, Neuro-Oncology, Gastrointestinal Oncology, Head & Neck Oncology, Thoracic Oncology, Nuclear Medicine, Interventional Radiology, Oncopathology, Pain & Palliative Care, and Plastic & Reconstructive Surgery. These departments work collaboratively to ensure comprehensive management of both common and rare cancer conditions while supporting patients throughout their treatment journey.
Research and academics are integral components of MGCH's mission. The institute actively participates in national and international clinical trials aimed at improving cancer treatment outcomes and advancing oncology research. The hospital collaborates with academic institutions, medical colleges, and research organizations to conduct translational research, clinical studies, and educational programs. MGCH is also recognized as a teaching institution offering DNB super-specialty programs in various oncology disciplines, contributing significantly to the training of future cancer specialists.
Advanced diagnostic services further strengthen the hospital's clinical capabilities. Patients have access to pathology, molecular diagnostics, PET-CT imaging, CT scans, MRI, nuclear medicine imaging, flow cytometry, and specialized cancer diagnostic investigations. These technologies enable early detection, accurate staging, and precise treatment planning, which are critical for improving survival outcomes.
MGCH also places strong emphasis on cancer prevention and community outreach. Through awareness campaigns, screening programs, educational initiatives, and partnerships with healthcare organizations, the hospital works to promote early detection and reduce the burden of cancer in underserved populations. Community engagement and preventive healthcare remain key components of the institution's long-term mission.
With nearly two decades of oncology excellence, advanced technology, internationally recognized treatment protocols, robust research programs, and a commitment to compassionate care, Mahatma Gandhi Cancer Hospital & Research Institute continues to stand among India's leading cancer centers. The institution remains dedicated to advancing cancer treatment, improving survival rates, and providing hope to patients and families affected by cancer.
Services Offered
Surgical Oncology
Robotic Cancer Surgery
Medical Oncology
Chemotherapy
Immunotherapy
Targeted Therapy
Radiation Oncology
IMRT
IGRT
SBRT
SRS
Brachytherapy
Hemato-Oncology
Bone Marrow Transplantation (BMT)
Pediatric Oncology
Gynaec Oncology
Breast Oncology
Head & Neck Oncology
Neuro-Oncology
Uro-Oncology
Gastrointestinal Oncology
Thoracic Oncology
Nuclear Medicine
PET-CT Imaging
Interventional Oncology
Oncopathology
Pain & Palliative Care
Plastic & Reconstructive Surgery
Cancer Screening Programs
Cancer Rehabilitation Services
Clinical Trials
Genetic & Molecular Diagnostics
Preventive Oncology
Cancer Counseling Services
Survivorship Programs
Frequently Asked Questions
1. What is MGCH known for?
MGCH is known for comprehensive cancer care, robotic cancer surgery, bone marrow transplantation, advanced radiation therapy, medical oncology, and multidisciplinary cancer treatment programs.
2. Does MGCH provide bone marrow transplant services?
Yes. MGCH operates a dedicated Bone Marrow Transplant Unit offering both autologous and allogeneic stem cell transplantation for blood cancers and hematological disorders.
3. Does the hospital offer robotic cancer surgery?
Yes. MGCH is one of the leading centers for robotic-assisted cancer surgery and has successfully completed hundreds of robotic procedures across multiple specialties.
4. Is MGCH involved in cancer research?
Yes. The institute actively participates in clinical trials, oncology research programs, academic collaborations, and DNB oncology training programs.
5. Where is Mahatma Gandhi Cancer Hospital & Research Institute located?
MGCH is located at Plot No. 1, Sector 7, MVP Colony, Visakhapatnam, Andhra Pradesh – 530017, India.
Mahatma Gandhi Cancer Hospital & Research Institute (MGCH) is one of India's premier comprehensive cancer care institutions, dedicated exclusively to the prevention, diagnosis, treatment, rehabilitation, and research of cancer. Established in 2005 by Dr. Murali Krishna Voonna in Visakhapatnam, Andhra Pradesh, the institute has grown into one of the largest and most trusted cancer centers in South India. Over nearly two decades, MGCH has earned a reputation for providing world-class oncology services through advanced medical technology, multidisciplinary expertise, cutting-edge treatment modalities, and compassionate patient-centered care. The hospital was founded with the vision of making high-quality cancer treatment accessible and affordable while advancing research and innovation in oncology.
Located in MVP Colony, Visakhapatnam, the hospital serves patients from Andhra Pradesh, Telangana, Odisha, Chhattisgarh, West Bengal, and other parts of India. The institution functions as a comprehensive cancer care center where patients can access every stage of oncology care under one roof, including cancer screening, diagnostics, surgery, chemotherapy, radiation therapy, bone marrow transplantation, rehabilitation, pain management, palliative care, and survivorship programs. This integrated approach ensures seamless coordination between specialists and improves treatment outcomes for patients facing complex cancer diagnoses.
Over the years, MGCH has achieved remarkable growth and clinical milestones. What began as a small cancer care initiative evolved into a dedicated oncology hospital equipped with advanced treatment technologies, specialized cancer departments, and a highly skilled team of oncologists. The institute has treated more than 150,000 cancer patients and has become a referral center for complex oncology cases across Eastern and Southern India. The hospital's commitment to clinical excellence, innovation, and ethical healthcare has earned it numerous national and regional recognitions.
One of the hospital's major strengths is its multidisciplinary cancer care model. Patients benefit from coordinated treatment planning through specialized tumor boards where surgical oncologists, medical oncologists, radiation oncologists, radiologists, pathologists, and supportive care specialists collaborate to design personalized treatment strategies. This evidence-based approach ensures that every patient receives comprehensive care tailored to their specific cancer type, stage, and overall health condition.
The Department of Surgical Oncology is among the most advanced units at MGCH. The department performs a wide range of cancer surgeries involving breast cancer, head and neck cancer, gastrointestinal cancers, thoracic cancers, gynecological cancers, urological cancers, and complex oncological procedures. The surgical team utilizes advanced techniques, including minimally invasive and robotic-assisted surgeries, to improve precision, reduce complications, and enhance recovery outcomes. The hospital's robotic surgery program has successfully completed hundreds of procedures, making it one of the pioneers of robotic oncology surgery in the region.
Radiation Oncology is another center of excellence at MGCH. The department offers advanced radiotherapy treatments using modern linear accelerators, stereotactic radiosurgery (SRS), stereotactic body radiotherapy (SBRT), image-guided radiation therapy (IGRT), intensity-modulated radiation therapy (IMRT), adaptive radiotherapy, and brachytherapy. These technologies allow oncologists to precisely target cancer cells while minimizing damage to surrounding healthy tissues, resulting in improved treatment outcomes and reduced side effects.
The Medical Oncology Department provides comprehensive chemotherapy, targeted therapy, immunotherapy, hormonal therapy, and systemic cancer treatments. Medical oncologists work closely with other specialists to develop individualized treatment plans that align with international oncology guidelines and emerging research. The department manages a broad spectrum of cancers while focusing on maximizing treatment effectiveness and preserving quality of life.
MGCH is particularly recognized for its expertise in Hemato-Oncology and Bone Marrow Transplantation (BMT). The institute operates a dedicated Bone Marrow Transplant Unit that provides both autologous and allogeneic stem cell transplantation services. Patients with leukemia, lymphoma, multiple myeloma, aplastic anemia, thalassemia, and other blood disorders receive specialized treatment through advanced transplant protocols and comprehensive supportive care. The hospital has successfully completed hundreds of bone marrow transplant procedures, making it one of the leading centers for hematological cancer treatment in the region.
The Pediatric Oncology Department provides specialized care for children diagnosed with cancer and blood disorders. Pediatric oncologists, hematologists, nurses, psychologists, and supportive care teams work together to provide age-appropriate treatment plans and family-centered care. The department treats childhood leukemia, lymphomas, brain tumors, sarcomas, and other pediatric malignancies while focusing on both clinical outcomes and emotional well-being.
Women's cancer care is delivered through the Gynaec Oncology Department, which specializes in the diagnosis and treatment of cervical cancer, ovarian cancer, uterine cancer, vulvar cancer, and other gynecological malignancies. The department combines surgical expertise, chemotherapy, radiation therapy, and supportive care to provide comprehensive treatment for women facing cancer-related health challenges. Breast oncology services also play a major role in the hospital's cancer care programs, offering advanced screening, diagnosis, surgery, and reconstruction services.
The hospital also houses specialized departments for Uro-Oncology, Neuro-Oncology, Gastrointestinal Oncology, Head & Neck Oncology, Thoracic Oncology, Nuclear Medicine, Interventional Radiology, Oncopathology, Pain & Palliative Care, and Plastic & Reconstructive Surgery. These departments work collaboratively to ensure comprehensive management of both common and rare cancer conditions while supporting patients throughout their treatment journey.
Research and academics are integral components of MGCH's mission. The institute actively participates in national and international clinical trials aimed at improving cancer treatment outcomes and advancing oncology research. The hospital collaborates with academic institutions, medical colleges, and research organizations to conduct translational research, clinical studies, and educational programs. MGCH is also recognized as a teaching institution offering DNB super-specialty programs in various oncology disciplines, contributing significantly to the training of future cancer specialists.
Advanced diagnostic services further strengthen the hospital's clinical capabilities. Patients have access to pathology, molecular diagnostics, PET-CT imaging, CT scans, MRI, nuclear medicine imaging, flow cytometry, and specialized cancer diagnostic investigations. These technologies enable early detection, accurate staging, and precise treatment planning, which are critical for improving survival outcomes.
MGCH also places strong emphasis on cancer prevention and community outreach. Through awareness campaigns, screening programs, educational initiatives, and partnerships with healthcare organizations, the hospital works to promote early detection and reduce the burden of cancer in underserved populations. Community engagement and preventive healthcare remain key components of the institution's long-term mission.
With nearly two decades of oncology excellence, advanced technology, internationally recognized treatment protocols, robust research programs, and a commitment to compassionate care, Mahatma Gandhi Cancer Hospital & Research Institute continues to stand among India's leading cancer centers. The institution remains dedicated to advancing cancer treatment, improving survival rates, and providing hope to patients and families affected by cancer.
Services Offered
Surgical Oncology
Robotic Cancer Surgery
Medical Oncology
Chemotherapy
Immunotherapy
Targeted Therapy
Radiation Oncology
IMRT
IGRT
SBRT
SRS
Brachytherapy
Hemato-Oncology
Bone Marrow Transplantation (BMT)
Pediatric Oncology
Gynaec Oncology
Breast Oncology
Head & Neck Oncology
Neuro-Oncology
Uro-Oncology
Gastrointestinal Oncology
Thoracic Oncology
Nuclear Medicine
PET-CT Imaging
Interventional Oncology
Oncopathology
Pain & Palliative Care
Plastic & Reconstructive Surgery
Cancer Screening Programs
Cancer Rehabilitation Services
Clinical Trials
Genetic & Molecular Diagnostics
Preventive Oncology
Cancer Counseling Services
Survivorship Programs
Frequently Asked Questions
1. What is MGCH known for?
MGCH is known for comprehensive cancer care, robotic cancer surgery, bone marrow transplantation, advanced radiation therapy, medical oncology, and multidisciplinary cancer treatment programs.
2. Does MGCH provide bone marrow transplant services?
Yes. MGCH operates a dedicated Bone Marrow Transplant Unit offering both autologous and allogeneic stem cell transplantation for blood cancers and hematological disorders.
3. Does the hospital offer robotic cancer surgery?
Yes. MGCH is one of the leading centers for robotic-assisted cancer surgery and has successfully completed hundreds of robotic procedures across multiple specialties.
4. Is MGCH involved in cancer research?
Yes. The institute actively participates in clinical trials, oncology research programs, academic collaborations, and DNB oncology training programs.
5. Where is Mahatma Gandhi Cancer Hospital & Research Institute located?
MGCH is located at Plot No. 1, Sector 7, MVP Colony, Visakhapatnam, Andhra Pradesh – 530017, India.